Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Mar 15, 2009 (Vol. 29, No. 6)

Royal Botanic Gardens, Kew

  • Good scientific coverage
  • A bit scattered
I was curious about how useful this website would be. Many such botanical offerings are simply a display of pix from around their gardens. This one was different. To start with, there are sections of the site devoted exclusively to scientific research, data, and education. Within each category are sub-sections that will be of considerable interest to researchers. They include the Plant C-Values Database, the DNA Bank Database (22,000 samples of plant genomic DNA stored at -80°C), an annual Kew Scientist publication (in PDF format), course information (including the On Course PDF Newsletter), fellowships, internships, as well as standard information about the Kew collections that one might expect to see at a site like this. Overall, I was pleasantly surprised. While I won’t say that the website for scientists is as solid as the Kew gardens is for botany, overall I do think most visitors will find something useful here.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »